Detalhe da pesquisa
1.
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
N Engl J Med
; 389(24): 2221-2232, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37952131
2.
Familywise error for multiple time-to-event endpoints in a group sequential design.
Stat Med
; 2024 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38852994
3.
Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trial.
Clin Trials
; 19(6): 605-612, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053045
4.
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
N Engl J Med
; 377(8): 723-732, 2017 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-28605603
5.
Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) rationale and design.
Am Heart J
; 229: 61-69, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32916609
6.
Non-inferiority designs comparing placebo to a proven therapy for childhood pneumonia in low-resource settings.
Clin Trials
; 17(2): 129-137, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31814441
7.
Revisiting FDA Approval of Aducanumab.
N Engl J Med
; 385(9): 769-771, 2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320282
8.
Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7).
Diabetes Obes Metab
; 21(7): 1625-1633, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30850995
9.
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10).
Diabetes Obes Metab
; 21(6): 1437-1444, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30793465
10.
DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality.
Diabetologia
; 61(1): 58-65, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28913543
11.
Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
Diabetologia
; 61(1): 48-57, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28913575
12.
More data, less information? Potential for nonmonotonic information growth using GEE.
J Biopharm Stat
; 27(1): 135-147, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27049897
13.
Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1.
Am Heart J
; 179: 175-83, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27595693
14.
An evaluation of inferential procedures for adaptive clinical trial designs with pre-specified rules for modifying the sample size.
Biometrics
; 70(3): 556-67, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24766094
15.
Violations of the independent increment assumption when using generalized estimating equation in longitudinal group sequential trials.
Stat Med
; 33(29): 5041-56, 2014 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25224560
16.
Adaptive clinical trial designs with pre-specified rules for modifying the sample size: understanding efficient types of adaptation.
Stat Med
; 32(8): 1259-75; discussion 1280-2, 2013 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23081665
17.
Semaglutide for cardiovascular event reduction in people with overweight or obesity: SELECT study baseline characteristics.
Obesity (Silver Spring)
; 31(1): 111-122, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36502289
18.
Distribution-free inference on contrasts of arbitrary summary measures of survival.
Stat Med
; 31(16): 1722-37, 2012 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22362470
19.
Exploring the benefits of adaptive sequential designs in time-to-event endpoint settings.
Stat Med
; 30(11): 1199-217, 2011 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21538450
20.
The prevention and treatment of missing data in clinical trials.
N Engl J Med
; 367(14): 1355-60, 2012 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23034025